gastrointestinal tract, preventing acid-insult to the mucosa.Newer NSAIDsSelectivity for COX-2 can halve celebrex dose drug risk of peptic ulceration, and is the main feature of celecoxib, rofecoxib and other members of this drug class. Cox-2-selectivity does not seem to affect other side-effects of NSAIDs (most celebrex dose drug an increased risk.

during pregnancy (Graham et al., 2005). Doses should be taken as prescribed, due to risk of hepatotoxicity with overdoses (Wilkes et al, 2005).Other ADRsCommon ADRs, other than listed above, include: raised liver enzymes, headache, dizziness (Rossi, 2006).Uncommon ADRs include: celebrex dose drug failure, hyperkalaemia, confusion, bronchospasm, rash (Rossi, 2006). Ibuprofen may also rarely cause irritable celebrex dose drug syndrome symptoms.Newer NSAIDs: selective COX inhibitorsCOX-2 inhibitorsThe discovery of COX-2 celebrex dose drug 1991 by Daniel L. Simmons at celebrex dose drug Young University raised the hope of developing an effective NSAID without the gastric problems characteristic of these agents. It was thought that selective inhibition of COX-2 would result in anti-inflammatory action without disrupting gastroprotective prostaglandins.COX-1 is a constitutively expressed enzyme with a house-keeping role in regulating many normal physiological processes. One celebrex dose drug these is in the stomach lining, where prostaglandins serve a protective role, celebrex dose drug the.

(see above). The gastric mucosa protects itself from gastric acid with a celebrex dose drug of mucous, the secretion of which is stimulated by certain.